{"id":"clm_9BDCE06C7B01","entity":"nvidia","predicate":"partnership","value":"Novo Nordisk","value_json":{"feed":"nvidia-newsroom-archive","item":"https://nvidianews.nvidia.com/news/nvidia-partners-with-novo-nordisk-and-dcai-to-advance-drug-discovery","tags":{"v":2,"ai":true,"by":"claude-haiku-5-5","on":"2026-11-08","deal":{"kind":"partnership","purpose":"research_safety","counterparty":"Novo Nordisk","counterparty_type":"healthcare"},"themes":["health_science"]},"check":{"on":"2026-11-08","url":"https://nvidianews.nvidia.com/news/nvidia-partners-with-novo-nordisk-and-dcai-to-advance-drug-discovery","pages":1,"quote":"GTC Paris at VivaTech —NVIDIA today announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases.","outcome":"checked"},"evidence":"NVIDIA today announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases. The work supports Novo Nordisk’s agreement with DCAI to use the Gefion sovereign AI supercomputer.","extracted_by":"claude-haiku-5-5","primary_source":true},"valid_from":"2025-06-11","valid_to":null,"published":"2025-06-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Nvidia partnership: Novo Nordisk\", as of 2025-06-11. Claim clm_9BDCE06C7B01, https://asof.is/claim/clm_9BDCE06C7B01, accessed 2026-11-09. Source: https://nvidianews.nvidia.com/news/nvidia-partners-with-novo-nordisk-and-dcai-to-advance-drug-discovery.","url":"https://asof.is/claim/clm_9BDCE06C7B01","accessed":"2026-11-09"},"confidence":0.7,"status":"valid","assertable":true,"superseded_by":null,"supersedes":[],"first_seen_at":"2026-11-08T10:44:27.818647+00:00","updated_at":"2026-11-08T19:57:58.915199+00:00","sources":[{"url":"https://nvidianews.nvidia.com/news/nvidia-partners-with-novo-nordisk-and-dcai-to-advance-drug-discovery","tier":"primary","publisher":"NVIDIA","published_at":"2025-06-11T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-08","quote":"GTC Paris at VivaTech —NVIDIA today announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases.","url":"https://nvidianews.nvidia.com/news/nvidia-partners-with-novo-nordisk-and-dcai-to-advance-drug-discovery","excerpt":"NVIDIA today announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases. The work supports Novo Nordisk’s agreement with DCAI to use the Gefion sovereign AI supercomputer."},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"page-read":"its source page states the value and the date"}}}